This is an update on our previous client alerts, “Are Tariffs the New Ammunition to Combat the Fentanyl Crisis?” and “Updates on the Potential Trade Tariffs for the Fentanyl Epidemic.”...more
This is an update on our October 24, 2024, client alert, “Are Tariffs the New Ammunition to Combat the Fentanyl Crisis?” We reported that a Section 301 petition had been filed by a nonprofit, Facing Fentanyl, requesting that...more
11/12/2024
/ Bureau of Industry and Security (BIS) ,
China ,
Illegal Drugs ,
Imports ,
Mexico ,
Section 301 ,
Tariffs ,
Trade Relations ,
Trump Administration ,
US Trade Policies ,
USTR
On October 18, 2024, Facing Fentanyl, a nonprofit assembly of grassroots illicit fentanyl awareness groups, petitioned the Office of the U.S. Trade Representative (USTR) to double the 25% section 301 China tariffs on Chinese...more
On April 17, 2024, the U.S. Trade Representative (USTR) initiated another Section 301 investigation involving China. This one concerns the acts, policies and practices of China targeting the maritime, logistics and...more
In a highly anticipated development, on May 3, 2022, the United States Trade Representative (USTR) announced the initiation of a statutory process whereby USTR is expected to conduct a reassessment of the existing Section 301...more
On October 4, 2021, United States Trade Representative (USTR) Katherine Tai unveiled the contours of the Biden administration’s long-awaited trade policy with respect to China. As hoped for among many in the U.S. business...more